Tackling reproducibility in academic preclinical drug discovery.

Frye SV, Arkin MR, Arrowsmith CH, Conn PJ, Glicksman MA, Hull-Ryde EA, Slusher BS
Nat Rev Drug Discov. 2015 14 (11): 733-4

PMID: 26388229 · DOI:10.1038/nrd4737

The reproducibility of biomedical research on novel drug targets has become suspect. Here, we highlight how drug discovery centres embedded in academic institutions, but with a translational imperative, can help address this reproducibility crisis.

MeSH Terms (8)

Academic Medical Centers Animals Biomedical Research Drug Discovery Drug Evaluation, Preclinical Humans Reproducibility of Results Translational Medical Research

Connections (1)

This publication is referenced by other Labnodes entities: